Clinical Trial Update: Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of TAS-102 (trifluridine/tipiracil) in patients with metastatic colorectal cancer after standard chemoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED